DOP01: Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paperECCO'24Year: 2024
Authors: Rosini, F.(1);Feakins, R.M.(2)*;Borralho Nunes, P.(3);Driessen, A.(4);Gordon, I.O.(5);Zidar, N.(6);Baldin, P.(7);Christensen, B.(8);Danese, S.(9);Herlihy, N.(10);Iacucci, M.(11);Loughrey, M.B.(12);Magro, F.(13);Mookhoek, A.(14);Svrcek, M.(15);
(1)IRCCS- Azienda Ospedaliero-Universitaria di Bologna, Cellular Pathology, Bologna, Italy;(2)Royal Free London NHS Foundation Trust, Department of Cellular Pathology, London, United Kingdom;(3)Hospital Cuf Descobertas, Department of Pathology, Lisbon, Portugal;(4)University Hospital Antwerp, Department of Pathology, Antwerp, Belgium;(5)Robert J. Tomsich Pathology and Laboratory Medicine Institute, Department of Pathology, Cleveland, United States;(6)Institute of Pathology, Department of Cellular Pathology, Ljubljana, Slovenia;(7)Cliniques Universitaires St-Luc, Department of Pathology, Brussels, Belgium;(8)The Royal Melbourne Hospital Melbourne, Department of Gastroenterology, Melbourne, Australia;(9)IRCCS Ospedale and University Vita-Salute San Raffaele, - Department of Gastroenterology, Milan, Italy;(10)University College London Hospital NHS, Department of Cellular Pathology, London, United Kingdom;(11)APC Microbiome Ireland, College of Medicine and Health, Cork, Ireland;(12)Royal Victoria Hospital, Department of Cellular Pathology, Belfast, United Kingdom;(13)CINTESIS@RISE, Faculty Of Medicine Of The University Of Porto, Porto, Portugal;(14)Institute of Tissue Medicine and Pathology, Department of Cellular Pathology, Bern, Switzerland;(15)AP-HP- Hôpital Saint-Antoine, Department of Pathology, Paris, France;
DOP02: Developing explicit thresholds for outcomes to inform (GRADE) Evidence to Decision frameworks for Inflammatory Bowel Disease guidelines.ECCO'24Year: 2024
Authors: Shaban, N.(1)*;Sinopoulou, V.(2);Vuyyuru, S.(1);Moran, G.(3);Gordon, M.(2);
(1)Nottingham University Hospitals NHS Trust, Gastroenterology, Nottingham, United Kingdom;(2)University of Central Lancashire, School of Medicine and Dentistry, Preston, United Kingdom;(3)NIHR Nottingham Biomedical Research Centre- Nottingham University Hospitals NHS Trust, School of Medicine, Nottingham, United Kingdom;
